AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

This study is looking for people who are 80 years or older, or between 65 and 79 years old and considered generally 'unfit' by their doctor. You must have been newly diagnosed with a specific type of Large B-cell Lymphoma, and your cancer needs to be visible on scans and at a certain stage.

There are also some health requirements. For example, your body's main organs (like bone marrow, liver, kidneys, and heart) need to be working well. Overall, your doctor will assess if participating in the study is safe and appropriate for you.

However, you cannot join if you have certain other medical conditions, like a history of the cancer spreading to the brain, specific other types of lymphoma, uncontrolled infections, or major heart problems. You also cannot have received previous treatment for your lymphoma, or be on certain long-term medications that suppress your immune system, with some exceptions.

If you join this study, you'll be assigned to one of two treatment groups, which is decided randomly, like flipping a coin. You will receive either the combined treatment (R-mini-CHOP for two cycles followed by AZD0486) or R-mini-CHOP for six cycles. This will involve regular visits to the clinic for your treatments, which are usually given through a drip (intravenous infusion).

Throughout the study, you'll have regular medical check-ups, blood tests, and scans to monitor your health, how the treatment is working, and to check for any side effects. These assessments are crucial for the researchers to understand the safety and effectiveness of the treatments. The total duration of your active treatment will vary depending on which group you are in, and there will be follow-up appointments after your treatment finishes to see how you are doing long-term.